Key Takeaways
- Volume growth stalled, margins squeezed: Half-year volume grew just 3.4% as ice cream demand collapsed 40-50% and paint volumes fell ~8%, while EBITDA per kg dropped to ₹37-38 on higher rejections and manpower costs.
- Pharma is the torchbearer bet: Commercial production starts December-January across four segments, with management targeting ₹150 per kg EBITDA and framing it as the next IML-scale transformation.
- Patent enforcement turns defensive into offensive: Injunction orders secured against duplicators of the patented Q PACK design, with seizures beginning in September, protecting both margins and market size.
- Capacity build-out is aggressive and imminent: Three new plants (Panipat, Cheyyar, Mahad) plus pharma cleanrooms all go live between December and mid-2024, taking total capacity from 45,000 to 55,000-57,000 tons by year-end.
- What to watch next quarter: Whether pharma commercial production actually starts on schedule, the pace of Q PACK and Food & FMCG volume recovery in Q3, and any progress on RCP conversion price renegotiations with paint customers.
Volume & Segment Performance
- Overall volumes: Flattish Q2 with marginal ~5% growth; half-year volume growth only 3.4%, well below the double-digit full-year aspiration.
- Food & FMCG: 15% growth in Q2, but real growth closer to 10-12% after adjusting for a depressed base last year. Ice cream, which contributes ~50% of first-half Food & FMCG sales, saw demand fall 40-50% during summer months due to rains.
- Lubricants: Growth driven by continued movement of companies into IML and QR coding, with Shell moving grades into QR code. Management expects 7-10% annual growth for the next one to two years despite flat sector volumes.
- Paint: Volumes down ~8% as the company consciously dropped low-end paint companies facing pricing pressure, redirecting capacity to better products like Q PACK. Satara plant (Asian Paints) is back in operation but numbers still catching up; other paint companies excluding Asian Paints declined 2-3% in volume terms.
- Q PACK: Demand rise driven not just by edible oil prices but by new applications in cashews, fertilizer, nutrients and other sectors opened by marketing. Gemini Oil, one of the largest oil manufacturers, has adopted the 10-liter Q PACK and is advertising it.
- Exports: Growing from ₹1-2 crores to ₹5-6 crores, now exporting to USA. Management sees potential to reach 3-5% of sales in 3-5 years with better margins, but exports will never be a top contributor like 20% unless the product range changes drastically.
Lakshmana Rao: "None of the big players would go for that because they know they need in season capacities and volumes and also uninterrupted supplies. So, like what we - happens in the paint industry might happen over the next five to seven years in the food industry where you will have more pockets of competition coming up."
Margin Walk & Cost Pressures
- EBITDA per kg: Dropped to ₹37-38 range from higher levels, driven by three forces: increased manpower costs (up >14% this quarter as staff are hired and trained for new plants), higher rejection rates (up from 2% to 4-5%) from RCP material compatibility changes, and pricing pressure from customers on the RCP mix.
- Gross profit per kg: Fell from ₹89 to ₹83, mainly due to increased rejection rates and higher maintenance costs from RCP use.
- RCP material impact: The requirement for RCP material in paint and lube industries is causing more rejection and trial work, plus higher maintenance costs and power consumption. Management has started discussions with top paint companies to increase conversion prices to reflect the RCP burden, but these talks have only just begun.
- Food & FMCG margins: Still holding around ₹80 per kg EBITDA with not much price pressure, a bright spot in the margin picture.
- Competitive intensity in paint: Increased aggression from small paint players who use second RCP material arbitrarily and cut prices; the company sticks with the top 4-5 paint companies.
Lakshmana Rao: "Actually, we are taking up this point with all the top paint companies. Even our competitors are speaking that if you need to add RCP material, you also need to change the conversion prices. So, that discussion has just started. Probably in next few quarters, we may try to convince them for increasing the conversion price."
Pharma Packaging: The Next IML
- Strategic framing: Management positions pharma packaging as the torchbearer for growth over the next five to ten years, analogous to what IML did for the company ten years ago, with a focus on improving EBITDA first and revenue growth later.
- Timeline: Final stages of cleanroom work ongoing; commercial production expected to start in December for one line, with all four segments (tablet packs, OTC, effervescent tubes, canisters) up and running by January.
- Revenue visibility: Management estimates ₹60-70 crores turnover is achievable with the starting product mix, but declines to give FY25 guidance given the newness of the line. Capacity utilization clarity expected after one quarter, by end of March 2024.
- EBITDA potential: Confident of at least ₹150 per kg average across any products, a step-change from the current ₹37-38 corporate average.
- Customer engagement: Interactions underway with big pharma companies; one very large unnamed company has auditors coming in December/January. One product is an import substitute, and two are already in market with limited capacities.
- Pharma city opportunity: A pharma city is coming up at Hyderabad; management sees a one-to-two-year window to build capabilities and relationships as pharma companies ramp up production there.
- Design studio: Planning to add 1-2 engineers with pharma background to strengthen product development capabilities.
Lakshmana Rao: "Like what IML did ten years ago, we hope pharma will be able to do for our company in terms of improving the EBITDA especially, and taking us forward in revenue growth later."
Patent Defence & Q PACK Moat
- Patent granted: Received a patent for square packs (Q PACK) a few months ago after a four-to-five-year fight.
- Injunction orders: Obtained injunction orders against duplicators who copied the patented container design and manufactured it in unhygienic conditions at lower prices, impacting margins indirectly and market size. The Delhi High Court ordered seizure against one competitor; similar orders obtained from other high courts. Actions started from September.
- Growth outlook: Q PACKs expected to continue growing at 30-40% at least, if not 80%, driven by new application segments beyond edible oil.
Lakshmana Rao: "We have got the injunction orders against a couple of duplicators. We have copied our container as it is and manufacturing them in a very unscrupulous, unhygienic atmosphere and offering lower prices, impacting our margins indirectly and also our market size."
Capacity Expansion & New Plants
- Panipat plant: Commercial trials starting December 2023; commercial production from January 2024. Also the site of the first Food & FMCG plant in the north, with basic machinery of 4-6 machines to be set up by February/March 2024.
- Cheyyar plant: Trials in January 2024; ready for supplies by end of January or beginning of February 2024.
- Mahad plant: Land acquired and clearance received from Maharashtra government; registration formalities pending. Construction starting December 2023; first phase ready by June-July 2024.
- ABG plants: Two plants (Panipat and Payur) going into production by end of December or beginning of January.
- Total capacity: Expected to reach 55,000-57,000 tons by end of FY24, up from 45,000 tons at the beginning of the year.
- New paint line utilization: Uncertain and depends on how the new player's products are received in the market. Panipat and Cheyyar are the first two of six planned locations; demand is expected from these two plants to start.
Seasonality & Near-Term Outlook
- Q1 (best quarter): Driven by diaries and ice creams in Food & FMCG.
- Q2 (soft): Rains reduce consumption of ice creams and dairy products sharply.
- Q3 (mixed): Diwali in October is peak for paint; post-Diwali paint volumes generally dip. Q3 is historically the worst quarter, but October started on a good note with decent double-digit growth expected, mainly driven by Food & FMCG and Q PACK. Lubes and paint likely stagnant or showing slight growth. Management expects to close Q3 at around 14% growth.
- Full-year volume: Still positive on reaching double-digit volume growth for the full year; looking at around 14-15% volume growth in Q3, may slip a little to 8-9% but not severely down.
- Food & FMCG H2: Confident the second half will deliver more than 20-25% growth. Sweet boxes growth runs from August-September through October, tapering after Diwali.
- FY25 growth ambition: Still aiming at 18-20% growth range from FY25 onwards, driven by new plants and the pharma segment.
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Pharma commercial production | One line starting December, all four segments by January | Dec 2023 / Jan 2024 |
| Panipat plant commercial production | Trials December, production January | Jan 2024 |
| Cheyyar plant supplies | Trials January, ready end-Jan/early-Feb | Jan-Feb 2024 |
| Mahad plant first phase | Construction starts December, production by June-July | Jun-Jul 2024 |
| Panipat F&F plant | Basic machinery of 4-6 machines set up | Feb-Mar 2024 |
| ABG plants (Panipat & Payur) | Production start | End Dec 2023 / early Jan 2024 |
| Full-year volume growth | Double-digit, around 14-15% in Q3, may slip to 8-9% | FY24 |
| Food & FMCG H2 growth | More than 20-25% | H2 FY24 |
| EBITDA per kg (current year) | Continue in ₹37-38 range; Q4 may look up a bit due to pharma | FY24 |
| EBITDA per kg (next year) | Target ₹41-42 range with pharma addition and north plant F&F improvement | FY25 |
| Pharma revenue | ₹60-70 crores achievable with starting product mix; utilization clarity by end-March | FY25 (initial) |
| Pharma EBITDA per kg | At least ₹150 per kg average | From commencement |
| FY25 volume growth | 18-20% range | FY25 |
| Lubricant growth | 7-10% annual | Next 1-2 years |
| Q PACK growth | 30-40% at least | Ongoing |
| Food & FMCG growth | 25% guidance maintained | Next couple of years |
| Export contribution | 3-5% of sales | 3-5 years |
| Capacity | 55,000-57,000 tons | End FY24 |
Key Metrics
| Metric | Q2 FY24 |
|---|---|
| Volume growth | ~5% YoY, flattish quarter |
| Half-year volume growth | 3.4% |
| Revenue — Paint | ₹78.3 cr, tonnage 4,460 |
| Revenue — Lubes | ₹37.7 cr, tonnage 2,162 |
| Revenue — Food & FMCG | ₹32.86 cr, tonnage 1,040 |
| Revenue — Q PACK | ₹19.1 cr, tonnage 1,117 |
| IML share | 62% of volume, 66.7% of value |
| EBITDA per kg | ₹37.2 in Q2, ₹38 in H1 |
| Gross profit per kg | ₹83, down from ~₹89 (per an analyst's math) |
| Manpower cost increase | >14% YoY, driven by staffing for new plants |
| Rejection rate | 4–5%, up from ~2% previously due to RCP material adoption |
| Food & FMCG volume growth | 15% YoY in Q2, 14% in H1 |
| Paint volume decline | ~8% YoY, partly due to dropping low-end customers |
| Satara plant utilization | ~60% |
| Capex spent in H1 FY24 | ~₹54 cr |
| Full-year capex plan | ₹120–125 cr, with ₹20 cr term loan from Citibank |
| Installed capacity by end of FY24 | 55,000–57,000 tons, up from 45,000 tons at beginning of FY24 |
| Pharma capacity revenue potential | ₹60–70 cr turnover with starting product mix |
| Pharma EBITDA per kg target | at least ₹150 |
| Export turnover | ₹5–6 cr, <1% of overall sales |
| Full-year volume growth guidance | 8–9% possible, double-digit still targeted |
| FY25 EBITDA per kg target | ₹41, plus/minus 1 |